Search Prime Grants

W81XWH2210516

Project Grant

Overview

Grant Description
Development of Bio 300 injectable suspension to treat radiation-induced lung injury.
Awardee
Humanetics Corporation
Grant Program (CFDA)
12.420 - Military Medical Research and Development
Awarding Agency
U.S. Army Medical Research Acquisition Activity (USAMRAA) [DoD - USA - MEDCOM - MRDC]
Funding Agency
Medical Command (MEDCOM) [DoD - USA]
Place of Performance
Minneapolis, Minnesota 554355938 United States
Geographic Scope
Single Zip Code
Related Opportunity
None
Humanetics Corporation was awarded Bio 300 Injectable Suspension: Treating Radiation-Induced Lung Injury Project Grant W81XWH2210516 worth $5,132,520 from Medical Command in July 2022 with work to be completed primarily in Minneapolis Minnesota United States. The grant has a duration of 4 years and was awarded through assistance program 12.420 Military Medical Research and Development.

Status
(Ongoing)

Last Modified 10/10/22

Period of Performance
7/1/22
Start Date
6/30/26
End Date
85.0% Complete

Funding Split
$5.1M
Federal Obligation
$0.0
Non-Federal Obligation
$5.1M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to W81XWH2210516

Transaction History

Modifications to W81XWH2210516

Additional Detail

Award ID FAIN
W81XWH2210516
SAI Number
None
Award ID URI
None
Awardee Classifications
Small Business
Awarding Office
W81XWH W4PZ USA MED RSCH ACQUIS ACT
Funding Office
W91ZSQ W03J HQ CO USA MED DEV MAT CM
Awardee UEI
MSRQYLLQLYQ5
Awardee CAGE
4B2E0
Performance District
03
Senators
Amy Klobuchar
Tina Smith
Representative
Dean Phillips

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
Defense Health Program, Defense (097-0130) Department of Defense-Military Grants, subsidies, and contributions (41.0) $5,132,520 100%
Modified: 10/10/22